Patent ID: 11897927
Assignee: ADVAXIS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 42:
43. The recombinant Listeria strain of claim 42 wherein:
(a) the antigenic peptides comprise one or more or all of the peptides set forth in SEQ ID NOS: 486, 405, 489, 643, 377, 491, 437, 631, 487, 406, and 566;
(b) the antigenic peptides comprise one or more or all of the peptides set forth in SEQ ID NOS: 717, 707, 714, 704, 705, 715, 706, 716, and 763-768;
(c) the antigenic peptides comprise one or more or all of the peptides set forth in SEQ ID NOS: 486, 489, 643, 491, 560, 559, 542, 565, 490, 498, 569, 563, 558, and 780-782;
(d) the antigenic peptides comprise one or more or all of the peptides set forth in SEQ ID NOS: 437, 769, 560, 436, 770, 771, 642, 772, 773, 535, 559, 542, and 565;
(e) the antigenic peptides comprise one or more or all of the peptides set forth in SEQ ID NOS: 437, 436, 447, 585, 448, 442, 438, 439, and 774-779;
(f) the antigenic peptides comprise one or more or all of the peptides set forth in SEQ ID NOS: 471, 470, 489, 491, 447, 427, 437, 436, 783, 492, 784, 448, 431, 487, 785 and 559;
(g) the antigenic peptides comprise one or more or all of the peptides set forth in SEQ ID NOS: 560, 559, 542, 565, 569, 563, 552, 549, 545, 546, 555, and 548;
(h) the antigenic peptides comprise one or more or all of the peptides set forth in SEQ ID NOS: 566, 565, 563, 431, 786-790, 435, and 393;
(i) the antigenic peptides comprise one or more or all of the peptides set forth in SEQ ID NOS: 486, 489, 377, 491, 437, 559, 542, 565, 447, 569, 563, and 492; or
(j) the antigenic peptides comprise one or more or all of the peptides set forth in SEQ ID NOS: 437, 707, 714, 704, 560, 436, 559, 542, 447, 569, 563, 558, 552, and 830-833.